annb0t
Top 20
Illumina, Inc. ILMN recently entered into a collaboration with Broad Clinical Labs to rapidly streamline and scale single-cell projects with cutting-edge tools and workflows. Together, the companies aim to accelerate the development of a 5-billion cell atlas within the next three years.
ILMN Stockâs Trend in Response to the News
Following the Feb. 21 announcement, Illuminaâs shares lost 3.1% to close at $94.20 last Friday. The company has democratized sequencing over the past 20 year...
>>> Read more: ILMN Stock Might Rise From Collaboration With Broad Clinical Labs
ILMN Stockâs Trend in Response to the News
Following the Feb. 21 announcement, Illuminaâs shares lost 3.1% to close at $94.20 last Friday. The company has democratized sequencing over the past 20 year...
>>> Read more: ILMN Stock Might Rise From Collaboration With Broad Clinical Labs
